U.S. market Closed. Opens in 16 hours 55 minutes

UTHR | United Therapeutics Corporation Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for UTHR we got that it has strong fundamentals where Valuation is considered to be undervalued, Profitability is wealthy, Growth is exceptionally good and Health is strong.

Valuation (71%)

Company Industry
P/E Ratio (TTM) 14.08 -15.40
PEG Ratio (TTM) 1.10 -1.28
P/S Ratio (TTM) 5.77 47.91
P/B Ratio (TTM) 2.64 21.47
P/FCF Ratio (TTM) 17.19 5.35
Price to 5YR AVG Earnings Ratio 29.81 -0.30
Price to 5YR AVG FCF Ratio 32.87 -7.28

Profitability (70%)

Company Industry
ROA (TTM) 15.91% -2.96%
ROE (TTM) 18.82% 23.42%
Net Profit Margin (TTM) 40.87% -894.56%
ROIC 5YR AVG 15.38% 16.62%

Growth (83%)

4QTR AVG 3YR AVG 5YR AVG
EPS 5.33% 153.59% 108.64%
Revenue 4.69% 1.67% 8.02%
Net Income 4.08% 155.77% 111.12%
Cash Flow 70.18% 106.13% 74.88%

Health (67%)

Company Industry
Current Ratio (TTM) 4.35 5.73
Quick Ratio (TTM) 4.18 5.45
D/E Ratio (TTM) 0.09 -14.53
Interest Coverage (TTM) 22.72 3.88
Piotroski F-Score 5 5
Altman Z-Score 11.80 13.58
LTL to 5YR AVG FCF 0.65 0.21
Shares Outstanding Growth 5YR AVG 1.48% 117.96%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙